Healthcare Hopes Dashed: Insurers Backtrack on Prior Authorization Pledge as Patient Frustrations Mount

One year after the Trump administration heralded a significant step towards alleviating patient burdens, dozens of health insurers who signed a six-part pledge, optimistically dubbed the "June 2025 pledge," are now signaling a retreat from their initial commitments. This voluntary agreement, aimed at streamlining the often-contentious process of prior authorization for doctor-recommended care, appears to be faltering, leaving patients, their advocates, and medical professionals disillusioned and questioning the efficacy of self-regulation within the healthcare industry. Despite initial fanfare and claims of progress from industry groups, the prevailing sentiment on the ground is one of worsening conditions, with many describing the current state of affairs as unprecedented in its difficulty for patients seeking necessary medical treatments.

The Prior Authorization Conundrum: A System Under Fire

Prior authorization, also known as preauthorization or precertification, is a long-standing practice embedded within the American healthcare system. For decades, health insurers have mandated that patients or their medical teams seek explicit approval before proceeding with a vast array of treatments, procedures, or medications. The insurance industry steadfastly defends this practice, asserting that it serves as a vital mechanism to control spiraling healthcare costs, curb waste and fraud, and ultimately protect patients from potentially unnecessary or harmful interventions. Chris Bond, a spokesperson for AHIP, the health insurance industry trade group, articulated this stance, stating, "Prior authorization is a vital patient safeguard." It is invoked for an extensive range of services, from seemingly minor urgent care visits for issues like tick bites to life-saving, high-cost interventions such as cancer treatments.

However, the reality for many patients and providers is far from this idealized vision. For years, prior authorization has been a flashpoint of frustration, characterized by bureaucratic hurdles, lengthy delays, and outright denials that can have severe, even deadly, consequences. Physicians report spending countless hours each week navigating complex insurer requirements, diverting valuable time away from patient care. A 2023 survey by the American Medical Association (AMA) found that physicians and their staff spend an average of 14 hours per week on prior authorizations, with 88% of physicians reporting that prior authorization can lead to delays in care, and 33% reporting that it has led to a serious adverse event for a patient. This administrative burden not only strains medical practices but also contributes to physician burnout.

The public outcry against prior authorization reached a fever pitch in late 2024, exacerbated by high-profile incidents such as the tragic killing of UnitedHealthcare CEO Brian Thompson. This event, while extreme, underscored a national groundswell of anger and frustration among patients and doctors who have grown increasingly vocal about what they perceive as insurance companies prioritizing profits over patient well-being through aggressive denial tactics. It was against this backdrop of widespread public discontent and bipartisan consensus on the need for reform that the "June 2025 pledge" was announced. Mehmet Oz, then administrator of the Centers for Medicare & Medicaid Services (CMS), explicitly stated at the time that the industry pledge was a direct response to this palpable anger, noting, "There’s violence in the streets over these issues. Americans are upset about it."

The Promise of the "June 2025 Pledge"

Announced in 2024 under the Trump administration, with high-profile figures like Health and Human Services Secretary Robert F. Kennedy Jr. present, the "June 2025 pledge" was hailed as a landmark voluntary commitment by leading health insurers. The six-part initiative outlined several key areas where insurers promised to implement reforms aimed at easing the prior authorization process for patients and providers. While the full details of all six parts were not extensively publicized, core tenets included:

1. Reducing Barriers to Care: A general commitment to streamline the approval process and minimize unnecessary obstacles.
2. Enhancing Transparency: Pledges to provide clear, easy-to-understand explanations for authorization decisions and denials, a promise already enshrined in the Affordable Care Act but often poorly executed.
3. Improving Continuity of Care: A crucial promise to honor a 90-day grace period for patients switching insurance plans, allowing them to temporarily continue receiving services and medications authorized under their previous insurer, effective January 1, 2025.
4. Adopting New Technology: A commitment to standardize the electronic submission of prior authorization requests, with an ambitious target date of January 1, 2027, to move away from antiquated paper, phone, and fax-based systems.
5. Increasing Efficiency: Implementing processes to expedite approvals for routine or low-risk services.
6. Accountability and Reporting: Though vaguely defined, the pledge hinted at greater data collection and potential public reporting of prior authorization metrics.

At the time of its announcement, Oz expressed optimism, stating, "I’m looking forward to seeing the results," and foreshadowed the creation of "public dashboards" to track progress and ensure accountability. This promise of transparency and measurable improvement offered a glimmer of hope to a healthcare system weary of bureaucratic hurdles.

One Year On: A Landscape of Disillusionment

However, one year after the pledge’s announcement, the initial optimism has largely dissipated, replaced by a growing sense of skepticism and frustration. U.S. Rep. Greg Murphy (R-N.C.), a physician himself and co-chair of the GOP Doctors Caucus, minced no words in his assessment: "It has never been this bad for patients." He further dismissed the voluntary pledge as having "no teeth," highlighting the inherent limitations of commitments without regulatory enforcement. Patient advocate Sally Nix, who lives with a chronic disease and frequently navigates the prior authorization maze, echoed this sentiment, describing the pledge as merely "performative."

AHIP, the industry trade group, presented data claiming a significant achievement: the elimination of 6.5 million prior authorizations for patients since the announcement, representing an 11% reduction. While this figure might seem substantial on the surface, critics argue it paints an incomplete and potentially misleading picture. Mike Gartner, founder of Health Access Innovation, an organization dedicated to helping patients appeal insurance denials, contended that the 11% reduction "hides a lot of nuance." He specifically pointed out that patients requiring the costliest services, such as cancer treatment, continue to face disproportionately high rates of denial, suggesting that the reductions might be concentrated in lower-cost, less complex areas of care. Furthermore, AHIP’s data, while including medical services, explicitly excluded prescription medicines, a significant area where prior authorization often creates barriers. The trade group also failed to provide specific details on which services had been dropped from prior authorization or how these reductions varied across individual insurers, further fueling skepticism about the depth and breadth of the reported improvements.

Sabrina Corlette, a research professor at the Center on Health Insurance Reforms at Georgetown University, offered a critical analysis of the situation, explaining why voluntary pledges often fall short. "In the absence of clear rules, policies, standards, and mandates," she asserted, "insurance companies are going to do what makes sense for them to do financially." This highlights the fundamental tension between corporate financial incentives and patient access to care, suggesting that without external pressure, insurers will naturally gravitate towards policies that benefit their bottom line. The Department of Health and Human Services (DHS), which played a role in announcing the pledge, did not respond to inquiries for this report, leaving unclear how, or whether, the Trump administration is holding insurers accountable for their commitments. The promised "public dashboards" for evaluating progress and driving accountability have also failed to materialize, leaving a void in transparency and oversight.

Real-World Consequences: Patients Caught in the Crossfire

The impact of these unfulfilled promises is most acutely felt by patients and their families, who often find themselves entangled in a bewildering and emotionally draining battle with their insurers.

The Adler-Young Family’s Ordeal: A Battle for Continuity of Care

Betsy Adler and Justin Young of Stillwater, Minnesota, experienced the direct fallout of inconsistent insurer practices shortly after their daughter, Coco, was born with a severe heart defect in February. Having switched to Medica, an insurer that initially signed the industry pledge, Adler had diligently confirmed that her maternal-fetal specialists and hospital were in-network. However, soon after Coco’s birth, the family began receiving paperwork indicating out-of-network costs, quickly accruing over $4,000 in additional charges on top of their in-network bills. Adler, a psychotherapist, recounted frustrating attempts to resolve the issue, including a representative claiming she hadn’t submitted a primary care provider referral and a bizarre incident where Medica’s fax machine was supposedly down, preventing a required referral from reaching them.

This situation directly challenged one of the six key promises of the pledge: the 90-day grace period for "continuity of care" when patients switch plans, designed to prevent disruptions in treatment. However, as Georgetown’s Sabrina Corlette pointed out, the pledge’s wording often includes caveats. Insurers are not necessarily obligated to honor another company’s network parameters. Thus, Medica was not required to cover out-of-network providers as if they were in-network, even if those providers had been covered under the family’s previous plan. Faced with a critically ill child and the daunting prospect of a "war with Medica," Adler and Young made the difficult decision to switch insurance companies again when Coco was just a month old, solely to avoid further exorbitant out-of-network costs.

Jocelyn Austin: Retroactive Denials and Unpaid Bills

Jocelyn Austin, a 49-year-old from Amherst, New York, faced a different, yet equally devastating, challenge. After years of battling addiction to prescribed sleeping and anxiety pills, she sought inpatient substance abuse treatment last year. Her insurer, Independent Health (another initial pledge signatory), had approved her admission to the treatment center. Austin successfully completed the program and has been substance-free since her discharge. However, in December, she received a bill for over $12,000, indicating that Independent Health had retroactively denied payment for the treatment. This was in addition to the $10,000 she had already paid to meet her out-of-network deductible. The approval letters from Independent Health had contained a crucial, often overlooked, clause: "authorization is not a guarantee of claim payment."

Frank Sava, a spokesperson for Independent Health, defended the denial, stating that the services provided "were inconsistent with the care that was authorized" and that "the medical record did not sufficiently support what was billed." He added that these findings were reviewed and confirmed by an outside consultant. Despite an explanation of benefits from the insurer initially assigning responsibility for the cost to the "provider," Austin has faced persistent pressure from the treatment facility for payment. Her experience underscores a critical loophole in the pledge: nothing explicitly prevents insurance companies from retroactively denying payment, even after pre-approval, leaving patients vulnerable to unexpected and substantial financial burdens.

Sally Nix: The Prevalence of Post-Approval Denials

Sally Nix, the patient advocate, herself experienced a retroactive denial for injections to relieve chronic nerve pain, even after her insurer had initially processed the claim. She emphasized that the AHIP percentages "don’t tell the whole story," as insurers "are not including the data for the loopholes they create." She predicted that patients would increasingly encounter retroactive denials, highlighting how insurers can approve care upfront, only to refuse payment later, leaving patients to foot the bill.

Technological Roadblocks and Accountability Lapses

Another cornerstone of the "June 2025 pledge" was the commitment to modernize the prior authorization process through technology. Insurers agreed to adopt new standards for electronic submission of requests, with a goal of operational implementation by January 1, 2027. This initiative was seen as crucial, given CMS Director Chris Klomp’s revelation during the pledge announcement that over 50% of prior authorizations were still processed through inefficient paper, phone, or fax methods.

However, an update released by AHIP in April regarding this technology initiative revealed a significant setback: eight insurers that had initially signed the broader pledge did not sign onto the specific technology update. These non-committing insurers include Alignment Health Plan, EmblemHealth, HealthFirst, Independent Health, Medica, MVP Health Care, Point32Health, and SummaCare, collectively serving beneficiaries across a wide geographic span from California to New York.

The reasons cited for their reluctance varied. Jerry Slowey, a spokesperson for Alignment Health, which offers Medicare Advantage policies in several states, stated that AHIP’s approach to continuity of care "would have required the transfer of confidential member health information through a non-standardized process involving third-party participation," a level of data sharing they did not believe was contemplated in the original commitment. Medica’s spokesperson, Greg Bury, echoed similar concerns, acknowledging support for standardization but citing a "significant technical and operational hurdle" that the company was not able to commit to at this time. Interestingly, after KFF Health News raised questions about its absence, EmblemHealth later stated it "will sign onto the commitment." AHIP spokesperson Chris Bond expressed optimism that "more plans will be added over the coming months," acknowledging, however, that "there is still significant work ahead." This fractured commitment to technological modernization raises serious doubts about the industry’s ability to meet the 2027 deadline and effectively streamline the prior authorization process.

The broader issue of accountability also remains unaddressed. Despite Mehmet Oz’s earlier promise of federal government evaluation, "driving accountability," and "public dashboards," none of these mechanisms have materialized. Federal officials, like DHS, have remained silent on inquiries regarding how they are holding companies accountable. This lack of oversight reinforces the skepticism voiced by Rep. Murphy, who declared he has "zero faith" in the industry’s capacity to police itself, a belief he held when the pledge was announced and maintains today.

Broader Implications and the Call for Legislative Action

The unraveling of the "June 2025 pledge" underscores a critical tension in healthcare policy: the effectiveness of voluntary industry commitments versus the necessity of legislative mandates. While prior authorization reform enjoys rare bipartisan agreement in Washington, the current situation suggests that goodwill and self-regulation may not be sufficient to drive meaningful change.

The legislative branch, however, appears to be moving forward. On July 15, the House Ways and Means Committee unanimously advanced a bill that would compel Medicare Advantage plans to provide the federal government with a comprehensive list of all items and services subject to prior authorization, along with detailed data on denials and grievances. This proposed legislation represents a significant step towards mandatory transparency and accountability, offering a potential blueprint for broader reforms. Such measures, unlike voluntary pledges, carry the weight of law and penalties for non-compliance, aligning with Sabrina Corlette’s argument that "clear rules, policies, standards, and mandates" are essential for meaningful change.

The suspected increasing reliance on artificial intelligence (AI) by insurance companies to generate denials adds another layer of complexity. Mike Gartner and Rep. Murphy both voiced concerns that insurers are "crafting the pathways to basically deny things immediately with the hope that people will give up." If true, this could further automate and accelerate the denial process, making it even more challenging for patients to appeal decisions and access care.

The struggles surrounding the "June 2025 pledge" serve as a stark reminder of the immense power wielded by the insurance industry lobby, which Rep. Murphy frankly described as "the strongest lobby in this town." This influence often complicates legislative efforts to impose stricter regulations. As patients continue to face delays, financial distress, and emotional anguish in their pursuit of doctor-recommended care, the call for robust federal intervention and enforceable standards grows louder. The question remains whether the government will finally step in with definitive action, or if the healthcare system will continue to grapple with the significant work ahead in reforming a process that has become a major barrier to patient well-being.